These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33824100)

  • 1. Effect of M. chamomilla L. tea on chlorpromazine induced catalepsy: A neuroprotective study.
    Khan SS; Ikram R; Naeem S; Khatoon H; Anser H; Sikander B
    Pak J Pharm Sci; 2020 Sep; 33(5):1945-1953. PubMed ID: 33824100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial anti-Parkinson effects of camel milk in Chlorpromazineinduced animal model: Behavioural and histopathological study.
    Khatoon H; Najam R; Mirza T; Sikandar B
    Pak J Pharm Sci; 2016 Sep; 29(5):1525-1529. PubMed ID: 27731807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effect of diclofenac on chlorpromazine induced catalepsy in rats.
    Naeem S; Najam R; Khan SS; Mirza T; Sikandar B
    Metab Brain Dis; 2019 Aug; 34(4):1191-1199. PubMed ID: 31055785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NEUROMODULATORY EFFECTS OF THYMOQUINONE IN EXTENUATING OXIDATIVE STRESS IN CHLORPROMAZINE TREATED RATS.
    Safhi MM
    Acta Pol Pharm; 2016; 73(2):529-35. PubMed ID: 27180446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective potential of Beta vulgaris L. in Parkinson's disease.
    Nade VS; Kawale LA; Zambre SS; Kapure AB
    Indian J Pharmacol; 2015; 47(4):403-8. PubMed ID: 26288473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of glutamate and alpha2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats.
    Alam M; Danysz W; Schmidt WJ; Dekundy A
    Toxicol Appl Pharmacol; 2009 Oct; 240(2):198-207. PubMed ID: 19616571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NSAIDs ameliorate cognitive and motor impairment in a model of parkinsonism induced by chlorpromazine.
    Naeem S; Ikram R; Khan SS; Rao SS
    Pak J Pharm Sci; 2017 May; 30(3):801-808. PubMed ID: 28653925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taurine and coenzyme Q10 synergistically prevent and reverse chlorpromazine-induced psycho-neuroendocrine changes and cataleptic behavior in rats.
    Oyovwi MO; Nwangwa EK; Ben-Azu B; Edesiri TP; Emojevwe V; Igweh JC
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):717-734. PubMed ID: 33146779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.
    Nehru B; Verma R; Khanna P; Sharma SK
    Brain Res; 2008 Mar; 1201():122-7. PubMed ID: 18308296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the mGluR7 receptor to antiparkinsonian-like effects in rats: a behavioral study with the selective agonist AMN082.
    Konieczny J; Lenda T
    Pharmacol Rep; 2013; 65(5):1194-203. PubMed ID: 24399715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of mitochondrial ATP-sensitive potassium channels improves rotenone-related motor and neurochemical alterations in rats.
    Yang Y; Liu X; Long Y; Wang F; Ding JH; Liu SY; Sun YH; Yao HH; Wang H; Wu J; Hu G
    Int J Neuropsychopharmacol; 2006 Feb; 9(1):51-61. PubMed ID: 15927086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the alpha2-adrenoreceptor antagonist idazoxan against 6-hydroxydopamine-induced Parkinsonism in rats: multiple facets of action?
    Srinivasan J; Schmidt WJ
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jun; 369(6):629-38. PubMed ID: 15118809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Protective Effect of Korean Red Ginseng Against Rotenone-Induced Parkinson's Disease in Rat Model: Modulation of Nuclear Factor-κβ and Caspase-3.
    Zaafan MA; Abdelhamid AM; Ibrahim SM
    Curr Pharm Biotechnol; 2019; 20(7):588-594. PubMed ID: 31198107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and Neuroprotective Activity of Glucuronomannan Oligosaccharides in an MPTP-Induced Parkinson's Model.
    Liu Y; Jin W; Deng Z; Wang J; Zhang Q
    Mar Drugs; 2020 Aug; 18(9):. PubMed ID: 32842556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective Effects of Sulphated Agaran from Marine Alga Gracilaria cornea in Rat 6-Hydroxydopamine Parkinson's Disease Model: Behavioural, Neurochemical and Transcriptional Alterations.
    Souza RB; Frota AF; Sousa RS; Cezario NA; Santos TB; Souza LM; Coura CO; Monteiro VS; Cristino Filho G; Vasconcelos SM; da Cunha RM; Aguiar LM; Benevides NM
    Basic Clin Pharmacol Toxicol; 2017 Feb; 120(2):159-170. PubMed ID: 27612165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism.
    Abdin AA; Hamouda HE
    Neuropharmacology; 2008 Dec; 55(8):1340-6. PubMed ID: 18817789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by L-DOPA.
    Alam M; Mayerhofer A; Schmidt WJ
    Behav Brain Res; 2004 May; 151(1-2):117-24. PubMed ID: 15084427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buspirone improves the anti-cataleptic effect of levodopa in 6-hydroxydopamine-lesioned rats.
    Mahmoudi J; Nayebi AM; Samini M; Reyhani-Rad S; Babapour V
    Pharmacol Rep; 2011; 63(4):908-14. PubMed ID: 22001978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ameliorative effects of endurance training and Matricaria chamomilla flowers hydroethanolic extract on cognitive deficit in type 2 diabetes rats.
    Heidarianpour A; Mohammadi F; Keshvari M; Mirazi N
    Biomed Pharmacother; 2021 Mar; 135():111230. PubMed ID: 33434853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of mercuric chloride and lead acetate treatment during the second stage of rapid post-natal brain growth on the behavioral response to chlorpromazine and on delta-ALA-D activity in weaning rats.
    Rocha JB; Rocha LK; Emanuelli T; Pereira ME
    Toxicol Lett; 2001 Dec; 125(1-3):143-50. PubMed ID: 11701233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.